News · The Korea Times·

Drugmaker Yuhan's historic headquarters wins Korea's top architectural honor

Predicted impact: Medium· Actual: +10.2% vs sector, volume 2.7× normal (5 trading days)

Lazertinib quarterly sales above $300M is meaningful, but already reported in the last 14 days.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.